申请人:GLAXOSMITHKLINE LLC
                            
                            
                                公开号:WO2014008223A2
                            
                            
                                公开(公告)日:2014-01-09
                            
                            This invention relates to novel spirocyclic piperidines according to Formula (I) which are inhibitors of fatty acid synthase (FAS), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.